Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methyltransferase like 21A pseudogene 1 (METTL21AP1) is a segment of DNA in the human genome similar in sequence to the METTL21A gene but has lost its protein-coding function due to disabling mutations or sequence degeneration[3][4][5]. As a pseudogene, METTL21AP1 is generally considered nonfunctional at the protein level. It may be transcribed in some contexts, and, like other pseudogenes, has the theoretical potential to perform regulatory functions at the RNA level, such as influencing gene expression through RNA interference, acting as a microRNA decoy, or affecting mRNA stability[2]. However, no such specific regulatory functions or roles related to disease or therapy have been established for METTL21AP1 to date[4][3][5]. Pseudogenes like METTL21AP1 are mostly important in evolutionary biology and genomics studies, but are not considered canonical targets in drug discovery or therapeutic development.
None (As there is no known drug interaction, mechanism of action does not apply.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methyltransferase like 21A pseudogene 1 (METTL21AP1).